Islet cell and glutamic acid decarboxylase antibodies present at diagnosis of diabetes predict the need for insulin treatment: A cohort study in young adults whose disease was initially labeled as type 2 or unclassifiable diabetes

Diabetes Care

Volumn 22, Issue 3, 1999, Pages 409-412

  Littorin, Bengt ^a,i   Sundkvist, Goran ^b   Hagopian, William ^h   Landin Olsson, Mona ^b   Lernmark, Åke ^h   Östman, Jan ^c   Arnqvist, Hans J ^d   Blohme, Goran ^e   Bolinder, Jan ^c   Eriksson, Jan W ^f   Lithner, Folke ^f   Scherstén, Bengt ^a   Wibell, Lars ^g  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^d LINKÖPING UNIVERSITY   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^g UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ Sodervarn Prim Hlth Care Ctr   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE DECARBOXYLASE; INSULIN; ORAL ANTIDIABETIC AGENT; PANCREAS ISLET CELL ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIET THERAPY; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HUMAN; IMMUNOFLUORESCENCE TEST; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PREDICTION; RADIOASSAY; SWEDEN;

EID: 0032972677     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.3.409     Document Type: Article

References (16)

1. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
2. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
3. Gottsāter A, Landin-Olsson M, Fernlund P, Lernmark Å, Sundkvist G: β-Cell function in relation to islet cell antibodies during the first 3 yr after the clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 16:902-910, 1993
4. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dahlquist G, Palmer J, Lernmark Å: Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 95:1505-1511, 1995
5. Landin-Olsson M, Karlsson FA, Lernmark Å, Sundkvist G, and the Diabetes Incidence Study in Sweden Group: Islet cell and thyrogastric antibodies in 633 consecutive 15-to 34-yr-old patients in the Diabetes Incidence Study in Sweden. Diabetes 41:1022-1027, 1992
6. Östman J, Arnquist H, Blohmé G, Lithner F, Littorin B, Nyström L, Sandström A, Scherstén B, Wall S, Wibell L: Epidemiology of diabetes mellitus in Sweden: results of the first year of a prospective study in the population age group 15-34 years. Acta Med Scand 220:437-445, 1986
7. Blohmé G, Nyström L, Arnquist H, Lithner F, Littorin B, Olsson PO, Scherstén B, Wibell L, Östman J: Male predominance of type 1 (insulin-dependent) diabetes mellitus in young adults: results from a 5-year prospective nationwide study of the 15-34 year age group in Sweden. Diabetologia 35:56-62, 1992
8. Berger B, Stenström G, Yue-Fang C, Sundkvist G: The prevalence of diabetes in a Swedish population of 280,411 inhabitants: a report from the Skaraborg Diabetes Registry. Diabetes Care 21:546-548, 1998
9. Littorin B, Sundkvist G, Scherstén B, Nyström L, Arnqvist HJ, Blohmé G, Lithner F, Wibell L, Östman J: Patient administrative system as a tool to validate the ascertainment in the Diabetes Incidence Study in Sweden (DISS). Diabetes Res Clin Pract 33:129-133, 1996
10. Landin-Olsson M, Sundkvist G, Lernmark Å: Prolonged incubation in the two-colour immunofluorescence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 30:327-332, 1987
11. Schmidli RS, Colman PG, Bonifacio E, Bottazzo GF, Harrison LC, and participating laboratories: High level of concordance between assays for glutamic acid decarboxylase antibodies: the first international glutamic acid decarboxylase antibody workshop. Diabetes 43:1005-1009, 1994
12. Arnqvist HJ, Littorin B, Scherstén B, Nyström L, Blohmé G, Lithner F, Wibell L, Östman J: Difficulties in classifying diabetes at presentation in young adults. Diabet Med 10:606-613, 1993
13. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
14. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
15. Wroblewski M, Gottsäter A, Lingärde F, Fernlund P, Sundkvist G: Gender, autoantibodies, and obesity in newly diagnosed diabetic patients aged 40-75 years. Diabetes Care 21:250-255, 1998
16. Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R: UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. Lancet 350:1288-1293, 1997